SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Grants Priority Review To GlaxoSmithKline’s Tykerb

November 17, 2006 | 
1 min read
Nov. 16 (Bloomberg) -- GlaxoSmithKline Plc said the U.S. Food and Drug Administration gave fast-track status to its application for the experimental drug Tykerb for breast cancer, the most common cancer among women.

>>> Discuss This Story

Regulatory Europe
GlaxoSmithKline Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Success to win in business competition, overcome obstacles or motivation to solve problem and lead company achievement concept, confident businessman leader jump high over 3 hurdles to be winner.
Approvals
Biogen Bounces Back With FDA Nod for High-Dose Spinal Muscular Atrophy Drug
March 30, 2026
 · 
3 min read
 · 
Tristan Manalac
Business people and concepts vector art exit
Government
After Speaking out of Turn, Malone Steps Down From Vaccine Committee
March 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Innovation - Think differently - Being different, taking risky, move for success in life -The graphic of rocket also represents the concept of courage, enterprise, confidence, belief, fearless, daring,
Gene therapy
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
March 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Silhouette of a business person on the top of a mountain peak in sunset background. Winner and conquer of businessman concept.
Approvals
Denali Delivers ‘Welcome Positive’ for Rare Disease Space With FDA’s Hunter Syndrome Nod
March 26, 2026
 · 
3 min read
 · 
Tristan Manalac